Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05615415 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

StatusActive, Not Recruiting
PhaseNot specified
Started2022-02-15
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2026 → Dec 31, 2027
See other at-risk trials from NYU Langone Health

Amendment history

2026-10-01
Primary completion pushed: 2026-12-31 → 2027-12-31
Completion pushed: 2026-12-31 → 2027-12-31
2025-11-26
Study Status, Study Design v4
Primary completion date2025-12-31→2026-12-31
Completion date2025-12-31→2026-12-31
2025-01-13
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v3
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2024-12-31→2025-12-31
Completion date2024-12-31→2025-12-31
Study sitesdetails revised at 1 of 1 site
2024-02-22
Study Status v2
Primary completion date2023-12-31→2024-12-31
Completion date2023-12-31→2024-12-31
2023-09-26
Study Status, Eligibility v1
Eligibility criteria+11 characters
[...] CR test results provided by the NYU EMR or subject records. WeInvestigators will further record the clinical history and perform nucleo [...]
2022-11-07
Original filing
The overarching goal of this study is to develop PET/MR techniques for the diagnosis of neuropsychiatric post-acute sequelae (PASC) of SARS-CoV-2. The central hypothesis is that immunological and cerebrovascular dysfunction after acute SARS-CoV-2 infections mediate neuropsychiatric PASC (NP-PASC).
Trial Details
NCT Number NCT05615415
Lead Sponsor NYU Langone Health
Conditions Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
Enrollment 30 participants
Start Date 2022-02-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-30